Bioabsorbable Vascular Scaffolds Market Trends and Segments Forecast To 2028
Precision Business Insights published a research report on “Bioabsorbable Vascular Scaffolds Market By Product Type (Biological, Biosynthetic), By Material Type (Metal based BVS, Polymer based BVS), By Application (Coronary Artery Stents, Peripheral Artery Stents), By End-User (Hospitals, Cardiac Centres, Ambulatory Surgical Centres) and Geography - Global/Region/Country Forecast to 2028”.
Coronary heart disease, cerebrovascular
illness, peripheral arterial disease, rheumatic heart disease, congenital heart
disease, deep vein thrombosis, and pulmonary embolism are the most common
cardiovascular disorders, which impact millions of individuals around the
world. The prevalence of cardiovascular diseases has risen dramatically,
particularly in Asia and the Pacific. The prevalence of cardiovascular diseases
is higher in Western countries such as the United States, the United Kingdom,
Germany, France, and Russia. Patients with various types of cardiovascular disorders
benefit from bioresorbable vascular scaffolds such as poly-L-lactide (PLLA)
bioresorbable scaffolds, metallic bioresorbable scaffolds, and hybrid
bioresorbable scaffolds. The number of people with cardiovascular disorders
admitted to hospitals, both inpatient and outpatient, has risen dramatically.
For the treatment of CVDs, a shift from traditional metallic stents to
bioresorbable vascular scaffolds has been noted.
View
detailed report description here https://precisionbusinessinsights.com/market-reports/global-bioabsorbable-vascular-scaffolds-market/
One of the primary factors driving the
growth of the bioresorbable scaffolds market is the rise in the prevalence of
cardiovascular diseases (CVD) among the global population. The bioresorbable
scaffolds market is expected to develop due to an increase in adoption for cardiovascular
procedures due to several benefits such as full absorption by the body and an
increase in the incidence of lifestyle-related disorders such as diabetes and
obesity, among others. The bioresorbable scaffolds market is also influenced by
the rise in adoption of bad lifestyle behaviours such as alcohol use, poor
diet, and lack of exercise, as well as advancements developed by key companies
to naturally restore arterial movement. Furthermore, changing lifestyles,
population expansion, an increase in the number of cardiovascular procedures,
and an increase in healthcare spending all benefit the bioresorbable scaffolds
market. Furthermore, in the forecast period of 2021 to 2028, research and
development initiatives to prevent vessel recoil that allows secretion of
anti-proliferative drugs expand profitable potential for bioresorbable
scaffolds market players. The high cost of bioresorbable scaffolds, on the
other hand, is projected to stifle the bioresorbable scaffolds market's growth.
In the forecast period of 2021-2028, the rising demand for vascular graft
devices for angioplasty and coronary artery disorders is expected to pose a
threat to the bioresorbable scaffolds market.
On the basis of material, the bioresorbable
scaffolds market is categorized into absorbable magnesium stent (AMS), poly
carbonate scaffold, polymeric scaffold, and others. On the basis of types, the
bioresorbable scaffolds market is classified into drug eluting coronary
scaffolds, everolimus-eluting device, sirolimus-eluting device, novolimus-eluting
device, and paclitaxel-eluting device. On the basis of applications, the
bioresorbable scaffolds market is divided into peripheral vascular
intervention, regulation of blood flow and others. On the basis of end users,
the bioresorbable scaffolds market is segregated into hospitals, clinics and
others.
Due to the large number of people suffering
from cardiovascular diseases, the rise in obese and diabetic populations, the
rise in stress and desk-bound lifestyles, the large geriatric population, and
the presence of a number of leading companies, North America dominates the
bioresorbable scaffolds market. Because of significant technological
advancements and a large number of patients suffering from various vascular
illnesses, Asia-Pacific is predicted to increase at the quickest rate from 2021
to 2028.
Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=15795
Some of the major key
players in the bioabsorbable vascular scaffolds market are Medtronic (U.S.) Abbott
Laboratories (U.S) Boston Scientific Corporation (U.S.) Biosensors
International Group, Ltd. (Singapore) Biotronik SE & Co. KG (Germany) C.R.
Bard Inc. (U.S.) Stentys SA (France) Svelte Medical Systems, Inc. (U.S.) REVA
Medical, Inc. (U.S.)
About
Precision Business Insights:
We are a market research company that strives to
provide the highest quality market research insights. Our diverse market
research experts are enthusiastic about market research and therefore produce
high-quality research reports. We have over 500 clients with whom we have a
good business partnership and capacity to provide in-depth research analysis
for more than 30 countries. In addition to deliver more than 150 custom
solutions, we already have accounts with the top five medical device
manufacturers.
Precision Business Insights offers a variety of cost-effective and
customized research services to meet particular research requirements. We are a
leading research service provider because of our extensive database built by
our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll
Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/
| D U N S® Number: 85278174
Comments
Post a Comment